List of works - Henriette Farkas

"Nuts and Bolts" of Laboratory Evaluation of Angioedema

scientific article published on 3 May 2016

A follow-up survey of patients with acquired angioedema due to C1-inhibitor deficiency

scientific article published on 20 November 2020

A novel assay to diagnose hereditary angioedema utilizing inhibition of bradykinin-forming enzymes

scientific article published on 15 October 2014

A novel prophylaxis with C1-inhibitor concentrate in hereditary angioedema during erythema marginatum.

scientific article published on 31 May 2017

Acquired angioedema associated with chronic hepatitis C

scientific article published on 01 April 1999

Acquired angioedema associated with primary antiphospholipid syndrome in a patient with antithrombin III deficiency

scientific article published on 18 January 2008

Activation of the ficolin-lectin pathway during attacks of hereditary angioedema

scientific article published on 16 July 2014

Acute abdominal attack of hereditary angioneurotic oedema associated with ultrasound abnormalities suggestive of acute hepatitis

scientific article published on 01 January 2002

Adverse effects of danazol prophylaxis on the lipid profiles of patients with hereditary angioedema.

scientific article

An abdominal attack of hereditary angio-oedema

scientific article published on 16 November 2012

Anti-cholesterol antibody levels in hereditary angioedema.

scientific article

Antibody-mediated inhibition of FXIIa blocks downstream bradykinin generation

scientific article published on 21 June 2018

Are these patients indeed resistant to treatment with C1 inhibitor concentrate?

scientific article published on 17 October 2011

Assessment of inhibitory antibodies in patients with hereditary angioedema treated with plasma-derived C1 inhibitor.

scientific article published on 24 October 2016

Association of celiac disease and hereditary angioedema due to C1-inhibitor deficiency. Screening patients with hereditary angioedema for celiac disease: is it worth the effort?

scientific article published on 01 March 2011

Association of celiac disease and hereditary angioneurotic edema

scientific article published on 01 October 2002

Atrial natriuretic peptide as a novel biomarker of hereditary angioedema

scientific article published on 04 March 2016

Bacteriuria increases the risk of edematous attacks in hereditary angioedema with C1-inhibitor deficiency.

scientific article published on 22 August 2016

Baseline level of functional C1-inhibitor correlates with disease severity scores in hereditary angioedema

scientific article published on 27 November 2009

Both positive and negative selection pressures contribute to the polymorphism pattern of the duplicated human CYP21A2 gene

scientific article

C1-inhibitor (C1-INH) autoantibodies in hereditary angioedema. Strong correlation with the severity of disease in C1-INH concentrate naïve patients

scientific article published on 05 June 2006

C1-inhibitor autoantibodies in SLE

scientific article published on 13 January 2010

Canadian 2003 International Consensus Algorithm For the Diagnosis, Therapy, and Management of Hereditary Angioedema.

scientific article published in September 2004

Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group

scientific article

Clinical management of hereditary angio-oedema in children.

scientific article

Common genetic variants of the human steroid 21-hydroxylase gene (CYP21A2) are related to differences in circulating hormone levels

scientific article

Complete kinetic follow-up of symptoms and complement parameters during a hereditary angioedema attack

scientific article published on 7 October 2017

Comprehensive study into the activation of the plasma enzyme systems during attacks of hereditary angioedema due to C1-inhibitor deficiency

scientific article

Current pharmacotherapy of bradykinin-mediated angioedema.

scientific article published on April 2013

Danazol therapy for hereditary angio-oedema in children

scientific article published on 01 September 1999

Deep venous thrombosis associated with acquired angioedema type II in a patient heterozygous for the mutation of factor V Leiden: effective treatment and follow-up for four years

scientific article published on 01 May 2006

Depressed activation of the lectin pathway of complement in hereditary angioedema

Diagnosis and treatment of bradykinin-mediated angioedema: outcomes from an angioedema expert consensus meeting

scientific article

Disease expression in women with hereditary angioedema.

scientific article published on 13 June 2008

Endothelial cell activation during edematous attacks of hereditary angioedema types I and II

scientific article published on 09 February 2014

Endothelial cell function in patients with hereditary angioedema: elevated soluble E-selectin level during inter-attack periods

scientific article published on 19 October 2011

Eradication of Helicobacter pylori and improvement of hereditary angioneurotic oedema

scientific article published in November 2001

Erythema Marginatum as an Early Symptom of Hereditary Angioedema: Case Report of 2 Newborns.

scientific article

Erythema marginatum preceding an acute oedematous attack of hereditary angioneurotic oedema

scientific article published on 01 October 2001

Esophageal leiomyoma incidentally recognized during an acute attack of hereditary angioneurotic edema

scientific article published on 01 May 2001

Estrogen-independent hereditary angioedema with normal C1 inhibitor function in a 10-year-old boy.

scientific article

Evaluation of avoralstat, an oral kallikrein inhibitor, in a Phase 3 hereditary angioedema prophylaxis trial: the OPUS-2 study.

scientific article published on 24 April 2018

F12-46C/T polymorphism as modifier of the clinical phenotype of hereditary angioedema

scientific article published on 6 August 2015

First report of icatibant treatment in a pregnant patient with hereditary angioedema

scientific article published on 19 April 2016

Flow mediated vasodilation assay indicates no endothelial dysfunction in hereditary angioedema patients with C1-inhibitor deficiency

scientific article published on 10 October 2018

Frequency of the virilising effects of attenuated androgens reported by women with hereditary angioedema

scientific article

Genetic Determinants of C1 Inhibitor Deficiency Angioedema Age of Onset.

scientific article published on 9 November 2017

Glucocorticoid receptor gene polymorphisms in hereditary angioedema with C1-inhibitor deficiency

scientific article published on 10 January 2017

HAEdb: a novel interactive, locus-specific mutation database for the C1 inhibitor gene.

scientific article published on January 2005

Health-related quality of life among children with hereditary angioedema.

scientific article published on 4 March 2017

Health-related quality-of-life with subcutaneous C1-inhibitor for prevention of attacks of hereditary angioedema

scientific article published on 29 January 2018

Helicobacter pylori Infection as a Triggering Factor of Attacks in Patients with Hereditary Angioedema

scientific article published on 01 June 2007

Hereditary angiodema: a current state-of-the-art review, VII: Canadian Hungarian 2007 International Consensus Algorithm for the Diagnosis, Therapy, and Management of Hereditary Angioedema.

scientific article published on January 2008

Hereditary angioedema: a decade of human C1-inhibitor concentrate therapy.

scientific article published on 29 August 2007

Hereditary angioedema: molecular and clinical differences among European populations.

scientific article published on 23 September 2014

High normal serum levels of C3 and C1 inhibitor, two acute-phase proteins belonging to the complement system, occur more frequently in patients with Crohn's disease than ulcerative colitis.

scientific article published in June 2003

Home treatment of attacks with conestat alfa in hereditary angioedema due to C1-inhibitor deficiency.

scientific article published in May 2014

Home treatment of hereditary angioedema with icatibant administered by health care professionals

scientific article published on 09 December 2011

Hypersensitivity reactions amongst Hungarian Patients with Hereditary Angioedema due to C1-Inhibitor Deficiency

scientific article published in 2023

Icatibant as acute treatment for hereditary angioedema in adults.

scientific article published on 28 April 2016

Icatibant for the treatment of hereditary angioedema with C1-inhibitor deficiency in adolescents and in children aged over 2 years.

scientific article

Idiopathic Nonhistaminergic Acquired Angioedema Versus Hereditary Angioedema

scientific article published on 30 April 2018

International consensus on the diagnosis and management of pediatric patients with hereditary angioedema with C1 inhibitor deficiency.

scientific article published on 09 August 2016

Investigational drugs in phase I and phase II clinical trials for hereditary angioedema

scientific article published on 11 December 2017

Lack of increased prevalence of immunoregulatory disorders in hereditary angioedema due to C1-inhibitor deficiency

scientific article published on 19 May 2011

Lanadelumab for the Prophylactic Treatment of Hereditary Angioedema with C1 Inhibitor Deficiency: A Review of Preclinical and Phase I Studies

scientific article published on 01 February 2019

Less severe clinical manifestations in patients with hereditary angioedema with missense C1INH gene mutations

scientific article published on 23 December 2012

Long-term danazol prophylaxis does not lead to increased carotid intima-media thickness in hereditary angioedema patients.

scientific article published on 30 October 2007

Long-term efficacy of danazol treatment in hereditary angioedema.

scientific article published on 18 October 2010

Management of hereditary angioedema in pediatric patients.

scientific article published on 27 August 2007

Management of pregnancies in a hereditary angioedema patient after treatment with attenuated androgens since childhood

scientific article published on 12 June 2014

Neutrophil activation during attacks in patients with hereditary angioedema due to C1-inhibitor deficiency

scientific article

Novel Vasoregulatory Aspects of Hereditary Angioedema: the Role of Arginine Vasopressin, Adrenomedullin and Endothelin-1.

scientific article published on 12 February 2016

Novel duplication in the F12 gene in a patient with recurrent angioedema

scientific article published on 09 August 2013

Oral Plasma Kallikrein Inhibitor for Prophylaxis in Hereditary Angioedema

article

Parameters of the classical complement pathway predict disease severity in hereditary angioedema

scientific article published on 20 January 2011

Pharmacological Management of Hereditary Angioedema with C1-Inhibitor Deficiency in Pediatric Patients.

scientific article

Prevention of hereditary angioedema attacks with a subcutaneous C1 inhibitor

scientific article published in March 2017

Prophylactic therapy in children with hereditary angioedema.

scientific article published on 24 September 2012

Psychometric Field Study of Hereditary Angioedema Quality of Life Questionnaire for Adults: HAE-QoL.

scientific article published on 8 March 2016

Randomized placebo-controlled trial of the bradykinin B₂ receptor antagonist icatibant for the treatment of acute attacks of hereditary angioedema: the FAST-3 trial.

scientific article published on 05 October 2011

Recombinant human C1-inhibitor in the treatment of acute angioedema attacks.

scientific article

Relationship between copy number of genes (C4A, C4B) encoding the fourth component of complement and the clinical course of hereditary angioedema (HAE)

article

Repeat treatment with icatibant for multiple hereditary angioedema attacks: FAST-2 open-label study

scientific article published on 21 September 2013

Reply

scientific article published on 16 March 2017

Reply: To PMID 24522092

scientific article published on 27 May 2014

Risk of thromboembolism in patients with hereditary angioedema treated with plasma-derived C1-inhibitor

scientific article published on 21 January 2016

Secreted Phospholipases A2 in Hereditary Angioedema With C1-Inhibitor Deficiency

scientific article published on 23 July 2018

Short-term prophylaxis in a patient with acquired C1-INH deficiency.

scientific article published on 24 April 2014

Short-term prophylaxis in hereditary angioedema due to deficiency of the C1-inhibitor--a long-term survey

Strong correlation of high EBNA-1-IgG levels with edematous attacks involving upper airway mucosa in hereditary angioedema due to C1-inhibitor deficiency

scientific article published on 03 December 2011

Successful outcome using C1-inhibitor concentrate in acute pancreatitis caused by hereditary angioedema

scientific article published on 01 January 2011

Successful pregnancy outcome after treatment with C1-inhibitor concentrate in a patient with hereditary angioedema and a history of four miscarriages

scientific article published on 11 August 2012

Successful prophylaxis with recombinant human C1 inhibitor in a patient with hereditary angioedema

scientific article published on 06 November 2014

Targeted next-generation sequencing for the molecular diagnosis of hereditary angioedema due to C1-inhibitor deficiency

scientific article published on 16 May 2018

The Hungarian HAE experience

scientific article published on 01 December 2003

The Levels of the Lectin Pathway Serine Protease MASP-1 and Its Complex Formation with C1 Inhibitor Are Linked to the Severity of Hereditary Angioedema.

scientific article

The effect of long-term danazol treatment on haematological parameters in hereditary angioedema

scientific article published on 25 February 2016

The efficacy of short-term danazol prophylaxis in hereditary angioedema patients undergoing maxillofacial and dental procedures

scientific article published on 01 April 1999

The influence of trigger factors on hereditary angioedema due to C1-inhibitor deficiency

scientific article published on 28 March 2014

The international WAO/EAACI guideline for the management of hereditary angioedema - the 2017 revision and update

scientific article published on 10 January 2018

The international WAO/EAACI guideline for the management of hereditary angioedema—The 2021 revision and update

scientific article published on 3 February 2022

The natural history of hereditary angioedema and the impact of treatment with human C1-inhibitor concentrate during pregnancy: a long-term survey.

scientific article published on 11 June 2010

The relationship between anxiety and quality of life in children with hereditary angioedema.

scientific article published on 10 July 2017

The role of ficolins and MASPs in hereditary angioedema due to C1-inhibitor deficiency

scientific article published on 12 January 2013

The role of the complement system in hereditary angioedema.

scientific article

Thyroid hormones and complement parameters in hereditary angioedema with C1-inhibitor deficiency.

scientific article published on 28 June 2016

Treatment Effect and Safety of Icatibant in Pediatric Patients with Hereditary Angioedema

scientific article published on 07 June 2017

Treatment of attacks with plasma-derived C1-inhibitor concentrate in pediatric hereditary angioedema patients

scientific article published on 11 October 2012

Treatment with C1-inhibitor concentrate does not induce IgM type anti-C1 inhibitor antibodies in patients with hereditary angioedema ⬇️

scientific article published on December 15, 2010

Ultrasonography in the diagnosis and monitoring of ascites in acute abdominal attacks of hereditary angioneurotic oedema.

scientific article published on October 2001

WAO Guideline for the Management of Hereditary Angioedema

scientific article published on December 2012

rhC1INH: a new drug for the treatment of attacks in hereditary angioedema caused by C1-inhibitor deficiency.

scientific article published on March 2011

List of works by Henriette Farkas

"Nuts and Bolts" of Laboratory Evaluation of Angioedema

A follow-up survey of patients with acquired angioedema due to C1-inhibitor deficiency

A novel assay to diagnose hereditary angioedema utilizing inhibition of bradykinin-forming enzymes

A novel prophylaxis with C1-inhibitor concentrate in hereditary angioedema during erythema marginatum.

Acquired angioedema associated with chronic hepatitis C

Acquired angioedema associated with primary antiphospholipid syndrome in a patient with antithrombin III deficiency

Activation of the ficolin-lectin pathway during attacks of hereditary angioedema

Acute abdominal attack of hereditary angioneurotic oedema associated with ultrasound abnormalities suggestive of acute hepatitis

Adverse effects of danazol prophylaxis on the lipid profiles of patients with hereditary angioedema.

An abdominal attack of hereditary angio-oedema

Anti-cholesterol antibody levels in hereditary angioedema.

Antibody-mediated inhibition of FXIIa blocks downstream bradykinin generation

Are these patients indeed resistant to treatment with C1 inhibitor concentrate?

Assessment of inhibitory antibodies in patients with hereditary angioedema treated with plasma-derived C1 inhibitor.

Association of celiac disease and hereditary angioedema due to C1-inhibitor deficiency. Screening patients with hereditary angioedema for celiac disease: is it worth the effort?

Association of celiac disease and hereditary angioneurotic edema

Atrial natriuretic peptide as a novel biomarker of hereditary angioedema

Bacteriuria increases the risk of edematous attacks in hereditary angioedema with C1-inhibitor deficiency.

Baseline level of functional C1-inhibitor correlates with disease severity scores in hereditary angioedema

Both positive and negative selection pressures contribute to the polymorphism pattern of the duplicated human CYP21A2 gene

C1-inhibitor (C1-INH) autoantibodies in hereditary angioedema. Strong correlation with the severity of disease in C1-INH concentrate naïve patients

C1-inhibitor autoantibodies in SLE

Canadian 2003 International Consensus Algorithm For the Diagnosis, Therapy, and Management of Hereditary Angioedema.

Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group

Clinical management of hereditary angio-oedema in children.

Common genetic variants of the human steroid 21-hydroxylase gene (CYP21A2) are related to differences in circulating hormone levels

Complete kinetic follow-up of symptoms and complement parameters during a hereditary angioedema attack

Comprehensive study into the activation of the plasma enzyme systems during attacks of hereditary angioedema due to C1-inhibitor deficiency

Current pharmacotherapy of bradykinin-mediated angioedema.

Danazol therapy for hereditary angio-oedema in children

Deep venous thrombosis associated with acquired angioedema type II in a patient heterozygous for the mutation of factor V Leiden: effective treatment and follow-up for four years

Depressed activation of the lectin pathway of complement in hereditary angioedema

Diagnosis and treatment of bradykinin-mediated angioedema: outcomes from an angioedema expert consensus meeting

Disease expression in women with hereditary angioedema.

Endothelial cell activation during edematous attacks of hereditary angioedema types I and II

Endothelial cell function in patients with hereditary angioedema: elevated soluble E-selectin level during inter-attack periods

Eradication of Helicobacter pylori and improvement of hereditary angioneurotic oedema

Erythema Marginatum as an Early Symptom of Hereditary Angioedema: Case Report of 2 Newborns.

Erythema marginatum preceding an acute oedematous attack of hereditary angioneurotic oedema

Esophageal leiomyoma incidentally recognized during an acute attack of hereditary angioneurotic edema

Estrogen-independent hereditary angioedema with normal C1 inhibitor function in a 10-year-old boy.

Evaluation of avoralstat, an oral kallikrein inhibitor, in a Phase 3 hereditary angioedema prophylaxis trial: the OPUS-2 study.

F12-46C/T polymorphism as modifier of the clinical phenotype of hereditary angioedema

First report of icatibant treatment in a pregnant patient with hereditary angioedema

Flow mediated vasodilation assay indicates no endothelial dysfunction in hereditary angioedema patients with C1-inhibitor deficiency

Frequency of the virilising effects of attenuated androgens reported by women with hereditary angioedema

Genetic Determinants of C1 Inhibitor Deficiency Angioedema Age of Onset.

Glucocorticoid receptor gene polymorphisms in hereditary angioedema with C1-inhibitor deficiency

HAEdb: a novel interactive, locus-specific mutation database for the C1 inhibitor gene.

Health-related quality of life among children with hereditary angioedema.

Health-related quality-of-life with subcutaneous C1-inhibitor for prevention of attacks of hereditary angioedema

Helicobacter pylori Infection as a Triggering Factor of Attacks in Patients with Hereditary Angioedema

Hereditary angiodema: a current state-of-the-art review, VII: Canadian Hungarian 2007 International Consensus Algorithm for the Diagnosis, Therapy, and Management of Hereditary Angioedema.

Hereditary angioedema: a decade of human C1-inhibitor concentrate therapy.

Hereditary angioedema: molecular and clinical differences among European populations.

High normal serum levels of C3 and C1 inhibitor, two acute-phase proteins belonging to the complement system, occur more frequently in patients with Crohn's disease than ulcerative colitis.

Home treatment of attacks with conestat alfa in hereditary angioedema due to C1-inhibitor deficiency.

Home treatment of hereditary angioedema with icatibant administered by health care professionals

Hypersensitivity reactions amongst Hungarian Patients with Hereditary Angioedema due to C1-Inhibitor Deficiency

Icatibant as acute treatment for hereditary angioedema in adults.

Icatibant for the treatment of hereditary angioedema with C1-inhibitor deficiency in adolescents and in children aged over 2 years.

Idiopathic Nonhistaminergic Acquired Angioedema Versus Hereditary Angioedema

International consensus on the diagnosis and management of pediatric patients with hereditary angioedema with C1 inhibitor deficiency.

Investigational drugs in phase I and phase II clinical trials for hereditary angioedema

Lack of increased prevalence of immunoregulatory disorders in hereditary angioedema due to C1-inhibitor deficiency

Lanadelumab for the Prophylactic Treatment of Hereditary Angioedema with C1 Inhibitor Deficiency: A Review of Preclinical and Phase I Studies

Less severe clinical manifestations in patients with hereditary angioedema with missense C1INH gene mutations

Long-term danazol prophylaxis does not lead to increased carotid intima-media thickness in hereditary angioedema patients.

Long-term efficacy of danazol treatment in hereditary angioedema.

Management of hereditary angioedema in pediatric patients.

Management of pregnancies in a hereditary angioedema patient after treatment with attenuated androgens since childhood

Neutrophil activation during attacks in patients with hereditary angioedema due to C1-inhibitor deficiency

Novel Vasoregulatory Aspects of Hereditary Angioedema: the Role of Arginine Vasopressin, Adrenomedullin and Endothelin-1.

Novel duplication in the F12 gene in a patient with recurrent angioedema

Oral Plasma Kallikrein Inhibitor for Prophylaxis in Hereditary Angioedema

Parameters of the classical complement pathway predict disease severity in hereditary angioedema

Pharmacological Management of Hereditary Angioedema with C1-Inhibitor Deficiency in Pediatric Patients.

Prevention of hereditary angioedema attacks with a subcutaneous C1 inhibitor

Prophylactic therapy in children with hereditary angioedema.